StonvexLoading…
StonvexStonvexStonvexCore line items from HLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $2.62B | $2.39B | $1.91B | $1.81B |
Operating Income | $527.02M | $502.57M | $373.23M | $341.74M |
Net Income | $425.70M | $399.71M | $280.30M | $254.22M |
EPS (Diluted) | $6.22 | $5.82 | $4.11 | $3.76 |
Total Assets | $4.31B | $3.82B | $3.17B | $2.97B |
Total Liabilities | $1.86B | $1.64B | $1.33B | $1.36B |
Cash & Equivalents | $1.19B | $971.01M | $721.24M | $714.44M |
Free Cash Flow OCF − CapEx | $681.82M | $808.91M | $261.73M | $85.54M |
Shares Outstanding | 68.43M | 68.66M | 68.16M | 67.59M |